Expression of ARID2 in primary hepatocellular carcinoma and its influence on proliferation and cell cycle

Li ZHANG,Wei WANG,Xiaobin LI,Jie LI,Jiazhong WANG,Xuejun SUN
DOI: https://doi.org/10.13753/j.issn.1007-6611.2018.02.001
2018-01-01
Abstract:Objective To investigate the expression level of ARID2 gene in hepatocellular carcinoma(HCC)tissues and cell lines, and to explore its effect on HCC cell proliferation and cell cycle. Methods The expression of ARID2 was detected by immunohisto-chemistry in specimens of primary cancer and their adjacent non-cancerous tissues in 60 patients with HCC. The expression of ARID2 was detected by qPCR in different differentiation of HCC cell lines. The small interfering RNA(siRNA)targeting ARID2 was transfect-ed into HepG2 cells,and the cell cycle changes and proliferation were detected by flow cytometry and MTT,respectively. Results The expression level of ARID2 in HCC tissues was significantly higher than that in adjacent tissues(P<0.01). The expression of AR-ID2 in HCC cell lines was significantly higher than that in LO2 cell lines(P<0.05). After siRNA targeting ARID2 was transfected, the cells in the G1phase were significantly increased(P<0.01),the S phase cells decreased significantly(P<0.01)and proliferation ability(P<0.05)of HepG2 cells were inhibited. Conclusion ARID2 can be used as an important biomarker for HCC,and it can affect the cell cycle and proliferation by targeting ARID2.
What problem does this paper attempt to address?